المؤلفون: Parisi S., Ruggeri L., Dan E., Rizzi S., Sinigaglia B., Ocadlikova D., Bontadini A., Giudice V., Urbani E., Ciardelli S., Sartor C., Cristiano G., Nanni J., Zannoni L., Chirumbolo G., Arpinati M., Lewis R. E., Bonifazi F., Marconi G., Martinelli G., Papayannidis C., Paolini S., Velardi A., Cavo M., Lemoli R. M., Curti A.

المساهمون: Parisi, S., Ruggeri, L., Dan, E., Rizzi, S., Sinigaglia, B., Ocadlikova, D., Bontadini, A., Giudice, V., Urbani, E., Ciardelli, S., Sartor, C., Cristiano, G., Nanni, J., Zannoni, L., Chirumbolo, G., Arpinati, M., Lewis, R. E., Bonifazi, F., Marconi, G., Martinelli, G., Papayannidis, C., Paolini, S., Velardi, A., Cavo, M., Lemoli, R. M., Curti, A.

مصطلحات موضوعية: acute myeloid leukemia, adoptive immune therapie, alloreactivity, cell dose, natural killer cell, Aged, Female, Histocompatibility Antigen, Histocompatibility Testing, Human, Immunotherapy, Adoptive, Killer Cells, Natural, Leukemia, Myeloid, Acute, Male, Middle Aged, Prognosi, Treatment Outcome

وصف الملف: ELETTRONICO

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/35173709; info:eu-repo/semantics/altIdentifier/wos/WOS:000756939900001; volume:12; firstpage:1; lastpage:6; numberofpages:6; journal:FRONTIERS IN IMMUNOLOGY; http://hdl.handle.net/11567/1078680Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85124594156

الإتاحة: https://doi.org/10.3389/fimmu.2021.804988Test
http://hdl.handle.net/11567/1078680Test

المؤلفون: Martello M., Poletti A., Borsi E., Solli V., Dozza L., Barbato S., Zamagni E., Tacchetti P., Pantani L., Mancuso K., Vigliotta I., Rizzello I., Rocchi S., Armuzzi S., Testoni N., Marzocchi G., Martinelli G., Cavo M., Terragna C.

المساهمون: Martello M., Poletti A., Borsi E., Solli V., Dozza L., Barbato S., Zamagni E., Tacchetti P., Pantani L., Mancuso K., Vigliotta I., Rizzello I., Rocchi S., Armuzzi S., Testoni N., Marzocchi G., Martinelli G., Cavo M., Terragna C.

مصطلحات موضوعية: Aged, Chromosome Deletion, Disease Progression, Female, Human, Male, Middle Aged, Multiple Myeloma, Mutation, Neoplasm Recurrence, Local, Prognosi, Tumor Suppressor Protein p53, Polymorphism, Single Nucleotide

وصف الملف: STAMPA

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/35082295; info:eu-repo/semantics/altIdentifier/wos/WOS:000747142500001; volume:12; issue:1; firstpage:15; lastpage:15; numberofpages:1; journal:BLOOD CANCER JOURNAL; http://hdl.handle.net/11585/880016Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85123600672; https://doi.org/10.1038/s41408-022-00610-yTest

الإتاحة: https://doi.org/10.1038/s41408-022-00610-yTest
http://hdl.handle.net/11585/880016Test

المؤلفون: Visco C., Marcheselli L., Mina R., Sassone M., Guidetti A., Penna D., Cattaneo C., Bonuomo V., Busca A., Ferreri A. J. M., Bruna R., Petrucci L., Cairoli R., Salvini M., Bertu L., Ladetto M., Pilerci S., Pinto A., Ramadan S., Marchesi F., Cavo M., Arcaini L., Coviello E., Romano A., Musto P., Massaia M., Fracchiolla N., Marchetti M., Scattolin A., Tisi M. C., Cuneo A., Porta M. D., Trentin L., Turrini M., Gherlinzoni F., Tafuri A., Galimberti S., Bocchia M., Cardinali V., Cilloni D., Corso A., Armiento D., Rigacci L., La Barbera E. O., Gambacorti-Passerini C., Visani G., Vallisa D., Venditti A., Selleri C., Conconi A., Tosi P., Lanza F., Candoni A., Krampera M., Corradini P., Passamonti F., Merli F.

المساهمون: Visco C., Marcheselli L., Mina R., Sassone M., Guidetti A., Penna D., Cattaneo C., Bonuomo V., Busca A., Ferreri A.J.M., Bruna R., Petrucci L., Cairoli R., Salvini M., Bertu L., Ladetto M., Pilerci S., Pinto A., Ramadan S., Marchesi F., Cavo M., Arcaini L., Coviello E., Romano A., Musto P., Massaia M., Fracchiolla N., Marchetti M., Scattolin A., Tisi M.C., Cuneo A., Porta M.D., Trentin L., Turrini M., Gherlinzoni F., Tafuri A., Galimberti S., Bocchia M., Cardinali V., Cilloni D., Corso A., Armiento D., Rigacci L., La Barbera E.O., Gambacorti-Passerini C., Visani G., Vallisa D., Venditti A., Selleri C., Conconi A., Tosi P., Lanza F., Candoni A., Krampera M., Corradini P., Passamonti F., Merli F.

مصطلحات موضوعية: Adult, Aged, 80 and over, Cohort Studie, Human, Middle Aged, Prognosi, SARS-CoV-2, Young Adult, COVID-19, Lymphoma

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34644385; info:eu-repo/semantics/altIdentifier/wos/WOS:000754251200013; volume:6; issue:1; firstpage:327; lastpage:338; numberofpages:12; journal:BLOOD ADVANCES; http://hdl.handle.net/2318/1846172Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85122929517; https://ashpublications.org/bloodadvances/article/6/1/327/477280/A-prognostic-model-for-patients-with-lymphoma-andTest; https://doi.org/10.1182/bloodadvances.2021005691Test

الإتاحة: https://doi.org/10.1182/bloodadvances.2021005691Test
http://hdl.handle.net/2318/1846172Test
https://ashpublications.org/bloodadvances/article/6/1/327/477280/A-prognostic-model-for-patients-with-lymphoma-andTest

المؤلفون: Larocca A., Leleu X., Touzeau C., Blade J., Paner A., Mateos M. -V., Cavo M., Maisel C., Alegre A., Oriol A., Raptis A., Rodriguez-Otero P., Mazumder A., Laubach J., Nadeem O., Sandberg A., Orre M., Torrang A., Bakker N. A., Richardson P. G.

المساهمون: Larocca A., Leleu X., Touzeau C., Blade J., Paner A., Mateos M.-V., Cavo M., Maisel C., Alegre A., Oriol A., Raptis A., Rodriguez-Otero P., Mazumder A., Laubach J., Nadeem O., Sandberg A., Orre M., Torrang A., Bakker N.A., Richardson P.G.

مصطلحات موضوعية: health-related quality of life, melflufen, melphalan flufenamide, patient-reported outcome, relapsed/refractory multiple myeloma, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocol, Biomarkers, Tumor, Dexamethasone, Female, Human, Male, Melphalan, Middle Aged, Multiple Myeloma, Neoplasm Grading, Neoplasm Staging, Patient Reported Outcome Measure, Treatment Outcome

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34671975; info:eu-repo/semantics/altIdentifier/wos/WOS:000709242300001; volume:196; issue:3; firstpage:639; lastpage:648; numberofpages:10; journal:BRITISH JOURNAL OF HAEMATOLOGY; http://hdl.handle.net/2318/1846953Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85117392564; https://doi.org/10.1111/bjh.17887Test

الإتاحة: https://doi.org/10.1111/bjh.17887Test
http://hdl.handle.net/2318/1846953Test

المؤلفون: Larocca, Alessandra, Leleu, Xavier, Touzeau, Cyrille, Bladé Creixenti, Juan, Paner, Agne, Mateos, M. V, Cavo, Michele, Maisel, Christopher, Alegre, Adrian, Oriol, Albert, Raptis, Anastasios, Rodriguez-Otero, Paula, Mazumder, Amitabha, Laubach, Jacob, Nadeem, Omar, Sandberg, Anna, Orre, Marie, TorrÃ¥ng, Anna, Bakker, Nicolaas A, Richardson, Paul G., Universitat Autònoma de Barcelona

مصطلحات موضوعية: Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols, Biomarkers, Tumor, Dexamethasone, Female, Humans, Male, Melphalan, Middle Aged, Multiple Myeloma, Neoplasm Grading, Neoplasm Staging, Patient Reported Outcome Measures, Treatment Outcome

وصف الملف: application/pdf

العلاقة: British Journal of Haematology; Vol. 196 Núm. 3 (february 2022), p. 639-648; https://ddd.uab.cat/record/270639Test; urn:10.1111/bjh.17887; urn:oai:ddd.uab.cat:270639; urn:scopus_id:85117392564; urn:articleid:13652141v196n3p639; urn:pmid:34671975; urn:pmc-uid:9135124; urn:pmcid:PMC9135124; urn:oai:pubmedcentral.nih.gov:9135124

الإتاحة: https://ddd.uab.cat/record/270639Test

المؤلفون: Passamonti F., Romano A., Salvini M., Merli F., Porta M. G. D., Bruna R., Coviello E., Romano I., Cairoli R., Lemoli R., Farina F., Venditti A., Busca A., Ladetto M., Massaia M., Pinto A., Arcaini L., Tafuri A., Marchesi F., Fracchiolla N., Bocchia M., Armiento D., Candoni A., Krampera M., Luppi M., Cardinali V., Galimberti S., Cattaneo C., La Barbera E. O., Mina R., Lanza F., Visani G., Musto P., Petrucci L., Zaja F., Grossi P. A., Bertu L., Pagano L., Corradini P., Derenzini E., Marchetti M., Scattolin A. M., Corso A., Tosi P., Gherlinzoni F., Passerini C. G., Cavo M., Fava C., Turrini M., Visco C., Zappasodi P., Merli M., Mora B., Vannucchi A. M.

المساهمون: Passamonti, F., Romano, A., Salvini, M., Merli, F., Porta, M. G. D., Bruna, R., Coviello, E., Romano, I., Cairoli, R., Lemoli, R., Farina, F., Venditti, A., Busca, A., Ladetto, M., Massaia, M., Pinto, A., Arcaini, L., Tafuri, A., Marchesi, F., Fracchiolla, N., Bocchia, M., Armiento, D., Candoni, A., Krampera, M., Luppi, M., Cardinali, V., Galimberti, S., Cattaneo, C., La Barbera, E. O., Mina, R., Lanza, F., Visani, G., Musto, P., Petrucci, L., Zaja, F., Grossi, P. A., Bertu, L., Pagano, L., Corradini, P., Derenzini, E., Marchetti, M., Scattolin, A. M., Corso, A., Tosi, P., Gherlinzoni, F., Passerini, C. G., Cavo, M., Fava, C., Turrini, M., Visco, C., Zappasodi, P., Merli, M., Mora, B., Vannucchi, A. M.

مصطلحات موضوعية: Covid-19, leukemia, lymphoma, myeloma, SARS-CoV-2, Adult, Aged, 80 and over, Antibodies, Viral, Female, Hematologic Neoplasm, Human, Immunoglobulin G, Male, Middle Aged, Seroconversion, Young Adult, Antibody Formation

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34272724; info:eu-repo/semantics/altIdentifier/wos/WOS:000673218400001; volume:195; issue:3; firstpage:371; lastpage:377; journal:BRITISH JOURNAL OF HAEMATOLOGY; http://hdl.handle.net/11380/1280502Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85110661399

الإتاحة: https://doi.org/10.1111/bjh.17704Test
http://hdl.handle.net/11380/1280502Test

المؤلفون: Auner H. W., Gavriatopoulou M., Delimpasi S., Simonova M., Spicka I., Pour L., Dimopoulos M. A., Kriachok I., Pylypenko H., Leleu X., Doronin V., Usenko G., Hajek R., Benjamin R., Dolai T. K., Sinha D. K., Venner C. P., Garg M., Stevens D. A., Quach H., Jagannath S., Moreau P., Levy M., Badros A., Anderson L. D., Bahlis N. J., Facon T., Mateos M. V., Cavo M., Chai Y., Arazy M., Shah J., Shacham S., Kauffman M. G., Richardson P. G., Grosicki S.

المساهمون: Auner H.W., Gavriatopoulou M., Delimpasi S., Simonova M., Spicka I., Pour L., Dimopoulos M.A., Kriachok I., Pylypenko H., Leleu X., Doronin V., Usenko G., Hajek R., Benjamin R., Dolai T.K., Sinha D.K., Venner C.P., Garg M., Stevens D.A., Quach H., Jagannath S., Moreau P., Levy M., Badros A., Anderson L.D., Bahlis N.J., Facon T., Mateos M.V., Cavo M., Chai Y., Arazy M., Shah J., Shacham S., Kauffman M.G., Richardson P.G., Grosicki S.

مصطلحات موضوعية: Adult, Age Factor, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocol, Bortezomib, Clinical Trials, Phase III as Topic, Dexamethasone, Drug Administration Schedule, Female, Frailty, Gastrointestinal Disease, Hematologic Disease, Human, Hydrazine, Kaplan-Meier Estimate, Male, Middle Aged, Multicenter Studies as Topic, Multiple Myeloma, Peripheral Nervous System Disease, Progression-Free Survival, Randomized Controlled Trials as Topic, Retrospective Studie, Severity of Illness Index, Triazoles

وصف الملف: STAMPA

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/33755235; info:eu-repo/semantics/altIdentifier/wos/WOS:000646325700001; volume:96; issue:6; firstpage:708; lastpage:718; numberofpages:11; journal:AMERICAN JOURNAL OF HEMATOLOGY; https://hdl.handle.net/11585/865006Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85104358050

الإتاحة: https://doi.org/10.1002/ajh.26172Test
https://hdl.handle.net/11585/865006Test

المؤلفون: Richardson P. G., Oriol A., Larocca A., Blade J., Cavo M., Rodriguez-Otero P., Leleu X., Nadeem O., Hiemenz J. W., Hassoun H., Touzeau C., Alegre A., Paner A., Maisel C., Mazumder A., Raptis A., Moreb J. S., Anderson K. C., Laubach J. P., Thuresson S., Thuresson M., Byrne C., Harmenberg J., Bakker N. A., Mateos M. -V.

المساهمون: Richardson P.G., Oriol A., Larocca A., Blade J., Cavo M., Rodriguez-Otero P., Leleu X., Nadeem O., Hiemenz J.W., Hassoun H., Touzeau C., Alegre A., Paner A., Maisel C., Mazumder A., Raptis A., Moreb J.S., Anderson K.C., Laubach J.P., Thuresson S., Thuresson M., Byrne C., Harmenberg J., Bakker N.A., Mateos M.-V.

مصطلحات موضوعية: Adult, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocol, Dexamethasone, Disease Progression, Drug Resistance, Neoplasm, Europe, Female, Human, Male, Melphalan, Middle Aged, Multiple Myeloma, Phenylalanine, Progression-Free Survival, Recurrence, Time Factor, United States

وصف الملف: STAMPA

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/33296242; info:eu-repo/semantics/altIdentifier/wos/WOS:000635371200008; volume:39; issue:7; firstpage:757; lastpage:767; numberofpages:11; journal:JOURNAL OF CLINICAL ONCOLOGY; https://hdl.handle.net/11585/865203Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85101703700

الإتاحة: https://doi.org/10.1200/JCO.20.02259Test
https://hdl.handle.net/11585/865203Test

المؤلفون: Richard S., Chari A., Delimpasi S., Simonova M., Spicka I., Pour L., Kriachok I., Dimopoulos M. A., Pylypenko H., Auner H. W., Leleu X., Usenko G., Hajek R., Benjamin R., Dolai T. K., Sinha D. K., Venner C. P., Garg M., Stevens D. A., Quach H., Jagannath S., Moreau P., Levy M., Badros A., Anderson L. D., Bahlis N. J., Facon T., Mateos M. V., Cavo M., Chang H., Landesman Y., Chai Y., Arazy M., Shah J., Shacham S., Kauffman M. G., Grosicki S., Richardson P. G.

المساهمون: Richard S., Chari A., Delimpasi S., Simonova M., Spicka I., Pour L., Kriachok I., Dimopoulos M.A., Pylypenko H., Auner H.W., Leleu X., Usenko G., Hajek R., Benjamin R., Dolai T.K., Sinha D.K., Venner C.P., Garg M., Stevens D.A., Quach H., Jagannath S., Moreau P., Levy M., Badros A., Anderson L.D., Bahlis N.J., Facon T., Mateos M.V., Cavo M., Chang H., Landesman Y., Chai Y., Arazy M., Shah J., Shacham S., Kauffman M.G., Grosicki S., Richardson P.G.

مصطلحات موضوعية: Adult, Aged, Antineoplastic Agent, Antineoplastic Combined Chemotherapy Protocol, Bortezomib, Cytogenetic Analysi, Dexamethasone, Female, Human, Hydrazine, Male, Middle Aged, Multiple Myeloma, Progression-Free Survival, Treatment Outcome, Triazole, Young Adult

وصف الملف: STAMPA

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34062004; info:eu-repo/semantics/altIdentifier/wos/WOS:000669628300001; volume:96; issue:9; firstpage:1120; lastpage:1130; numberofpages:11; journal:AMERICAN JOURNAL OF HEMATOLOGY; https://hdl.handle.net/11585/865100Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85109074071

الإتاحة: https://doi.org/10.1002/ajh.26261Test
https://hdl.handle.net/11585/865100Test

المؤلفون: Oliva S., Bruinink D. H., Rihova L., D'Agostino M., Pantani L., Capra A., van der Holt B., Troia R., Petrucci M. T., Villanova T., Vsianska P., Jugooa R., Brandt-Hagens C., Gilestro M., Offidani M., Ribolla R., Galli M., Hajek R., Gay F., Cavo M., Omede P., van der Velden V. H. J., Boccadoro M., Sonneveld P.

المساهمون: Oliva S., Bruinink D.H., Rihova L., D'Agostino M., Pantani L., Capra A., van der Holt B., Troia R., Petrucci M.T., Villanova T., Vsianska P., Jugooa R., Brandt-Hagens C., Gilestro M., Offidani M., Ribolla R., Galli M., Hajek R., Gay F., Cavo M., Omede P., van der Velden V.H.J., Boccadoro M., Sonneveld P.

مصطلحات موضوعية: Antineoplastic Combined Chemotherapy Protocol, Autograft, Bone Marrow Cell, Bortezomib, Dexamethasone, Disease-Free Survival, Female, Human, Lenalidomide, Male, Melphalan, Middle Aged, Neoplasm, Residual, Survival Rate, Flow Cytometry, Hematopoietic Stem Cell Transplantation, Multiple Myeloma

وصف الملف: STAMPA

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34083504; info:eu-repo/semantics/altIdentifier/wos/WOS:000657729400001; volume:11; issue:6; firstpage:1; lastpage:9; numberofpages:9; journal:BLOOD CANCER JOURNAL; http://hdl.handle.net/11585/865103Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85107145070; https://www.nature.com/articles/s41408-021-00498-0Test

الإتاحة: https://doi.org/10.1038/s41408-021-00498-0Test
http://hdl.handle.net/11585/865103Test
https://www.nature.com/articles/s41408-021-00498-0Test